ORIOLA Oriola Oyj

0.8204USD0.7480 EUR · HEL-1.84%Mkt Cap: 151.16M USDP/E: —

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and m…

Key Statistics

Company
Market Cap151.16M USD
Enterprise Value110.03M USD
Revenue (TTM)2.09B USD
Gross Profit183.38M USD
Net Income (TTM)-29.83M USD
Revenue/Share11.32 USD
Last Price0.8204 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees800
CountryFI
SectorHealthcare
IndustryPharmaceutical Retailers
ISINFI0009014351
Valuation
P/E (Trailing)—
P/E (Forward)7.48
PEG13.54
EV/EBITDA8.57
EV/Revenue0.05
P/S0.07
P/B1.50
EPS (TTM)-0.12 USD
EPS (Forward)0.11 USD
52W Range
0.79634% of range1.382
52W High1.382 USD
52W Low0.7963 USD
Profitability
Gross Margin8.77%
Oper. Margin0.14%
EBITDA Margin0.61%
Profit Margin-1.43%
ROE-26.98%
ROA-2.87%
ROIC13.44%
ROCE1.60%
Growth
Revenue Growth5.20%
Earnings Growth9.00%
Cash Flow & Leverage
Operating CF65.81M USD
CapEx (TTM)3.62M USD
FCF Margin0.44%
FCF Yield6.15%
Net Debt-41.13M USD
Net Debt/EBITDA-3.21
Net Debt/FCF-4.42
Balance Sheet
Debt/Equity0.69
Current Ratio0.77
Quick Ratio0.76
Book Value/Sh0.55 USD
Cash/Share0.65 USD
Dividends
Fwd Div Rate0.03 USD
Trail. Div Rate0.03 USD
Div. Yield3.94%
5Y Avg Yield3.68%
Payout Ratio200.00%
Ex-Div DateMar 26, 2026
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.9515 USD
Upside (mean)+16.0%
Target Range0.8774 USD – 1.097 USD
0.8774+16.0% to mean1.097
# Analysts4
Ownership
Shares Out.184.25M
Float137.77M
Insiders32.74%
Institutions12.60%
Technical
SMA 500.8826 (-7.0%)
SMA 2001.005 (-18.4%)
Beta0.47
S&P 52W Chg12.00%
Avg Vol (30d)149.68K
Avg Vol (10d)165.67K
Technical Indicators
RSI (14)39.8
MACD-0.0089
MACD Signal-0.0097
MACD Hist.+0.0008
BB Upper0.8744 USD
BB Middle0.8426 USD
BB Lower0.8109 USD
BB Width7.53%
ATR (14)0.0225 USD
Vol Ratio (20d)1.05x

About Oriola (HEL: ORIOLA)

›

Oriola (HEL: ORIOLA) is listed on Nasdaq Helsinki, where its shares trade in EUR. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 800 employees.

The shares were at 0.7480 EUR on 19 November 2026, down 31.7% over 52 weeks. Its 52-week range is 0.7260 EUR to 1.260 EUR: the price is 40.6% below the high and 3.0% above the low.

Its market capitalisation is 137.82M EUR. It pays a dividend yielding 3.94% (it pays out 200% of its earnings), against a median of 3.45% among the dividend payers in that peer group.

Oriola reports return on equity of -27.0%, an operating margin of 0.1% and revenue up 5.2% year over year.

It holds more cash than debt, a net cash position of 37.50M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Hold; their mean price target of 0.8675 EUR is 16.0% above the current price. The next earnings report is expected on 23 February 2027.